Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ACHthis companyAccendra Health, Inc.	$0.16	-0.2×	-0.47×	0.08×	9.86×	-8060.8%	46.7%	8.0%	-39.8%	238.8%	12.3%	-140.8%	-4.85×	8.88×	2.07×	0.58×	0.0%	4	0.17	2	C
ACRSAclaris Therapeutics, Inc.	$4.13	-5.68×	3.58×	47.18×	-5.45×	-120.4%	73.3%	-975.9%	-829.6%	-63.0%	-57.7%	-12.8%	0.02×	0.28×	0×	5.28×	0.0%	3	-0.36	1	D+
ALLOAllogene Therapeutics, Inc.	$0.93	-1.57×	1.03×	0×	-1.88×	-114.9%	0.0%	0.0%	0.0%	-65.3%	-52.8%	-49.5%	0.28×	-0.18×	-192.5×	7.93×	0.0%	2	-4.59	2	C
BIOABioAge Labs Inc.	$5.61	-5.91×	1.75×	52.85×	-3.66×	64.4%	100.0%	-1031.5%	-896.1%	-29.6%	-33.4%	-17.3%	0.02×	2.3×	-133.11×	14.24×	0.0%	3	4.03	3	B
CABACabaletta Bio, Inc.	$1.43	-1.34×	2×	0×	-1.02×	-67.4%	0.0%	0.0%	0.0%	-149.8%	-123.8%	-59.1%	0.24×	0.34×	-85.95×	2.77×	0.0%	3	-0.86	2	C+
CVRXCVRx, Inc.	$0.71	-3.48×	4.71×	3.27×	-3.43×	-18984.9%	85.3%	-90.5%	-94.1%	-135.6%	-56.0%	-22.0%	1.29×	0.53×	-8.8×	7.63×	0.0%	3	-10.02	1	D+
Peer median	—	-3.48×	2×	3.27×	-3.43×	-114.9%	73.3%	-90.5%	-94.1%	-65.3%	-56.0%	-22.0%	0.24×	0.34×	-85.95×	7.63×	0.0%	3	-0.86	2	—